Applications

1436 – Ovarian Repositioning

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type -
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome -

Application details

Reason for application

Amendment to MBS item.

Service or technology in this application

Ovarian repositioning for one or both ovaries as part of fertility preservation procedure prior to radiotherapy when the field and dose of radiotherapy has a high chance of causing infertility.

Type: Therapeutic

Medical condition this application addresses

The proposed medical service is relevant to female patients requiring fertility preservation prior to the start of gonadotoxic radiotherapy treatment with the intention of preserving a patient’s ovarian function.

Medical conditions requiring this service would be patients who have been diagnosed with (i) cancer, or (ii) non-malignant conditions requiring treatment with gonadotoxic radiotherapy.

(i) Cancer is a range of diseases where there is an uncontrolled growth of abnormal cells throughout the body. These abnormal cells have the ability to migrate from the original site and spread to distant sites of the body.

(ii)Other non-malignant conditions may include but are not limited to:

  • gastrointestinal diseases
  • rheumatologic
  • inflammatory bowel diseases (IBDs)
  • rheumatologic disorders
  • non-malignant haematologic conditions
  • autoimmune/vasculitis/glomerular disorders
  • gynaecologic conditions
  • metabolic diseases

Application documents

Meetings to consider this application

  • PASC meeting: -
  • ESC meeting: -
  • MSAC meeting: 31 March 2016